Search results for: Multi-Indication Medicines

Chittawan Poonsiri

4 September 2024

…Her past research includes economic evaluations of medicines and medical devices to inform policy decisions in Thailand. She is now focused on research related to health equity, antimicrobial resistance, cancer,…

Challenges and Solutions for Budget Impact Analysis of Gene Therapies

10 March 2025

…to be updated to reflect the proposal. This consulting report, Challenges and Solutions for Budget Impact Analysis of Gene Therapies, was commissioned and funded by Johnson & Johnson Innovative Medicines…

Bold politics – what about the economics?: An overview of President Trump’s ‘Most Favoured Nation’ Executive Order

2 June 2025

…in purchasing medicines, in contrast to the greater reliance on the private market seen in the U.S.” How is this Executive Order different to the previous one in 2020? The…

OHE Graduate School

…financed and delivered, how medicines are developed and the effects and benefits of health to people and society: you should apply. And if you have studied economics, there’s a whole…

Climate action is health action: OHE’s focus on sustainability

22 July 2025

…the UK will need to be replicated internationally to have any impact. Meaningful engagement, collaboration and action need to be taken now by governments, health systems, medicines regulators and companies…

Brendan Shaw

22 June 2026

…pharmaceutical industry. Prior to this he was Chief Executive and head of health policy at Medicines Australia, the association for the Australian innovative pharmaceutical industry. Brendan has also served as…

OHE responds to the NHS Productivity Commission report

22 September 2026

…as the Cancer Drugs Fund and Innovative Medicines Fund. A complete picture of NHS productivity needs to account for the health system as a whole, including NICE, regulators, and industry.”…

Dr Jayasree K. Iyer

24 September 2026

…pharmaceutical companies to expand access to essential medicines in low- and middle-income countries. With expertise in addressing complex issues like drug pricing, intellectual property, and industry R&D priorities, she connects…

Dr Samantha Roberts

24 September 2026

…accelerating health innovation. During her tenure at NICE, she oversaw a 25% increase in the speed of assessments of new medicines, delivered a 30-fold increase in digital and AI technology…